XML 59 R45.htm IDEA: XBRL DOCUMENT v3.24.1
Financial Instruments and Fair Value Measurements (Tables)
 12 Months Ended
Dec. 29, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Assets and Liabilities Measured on a Recurring Basis
The following tables provide a summary of the significant assets and liabilities that are measured at fair value on a recurring basis at the end of each period:
December 29, 2023 (Successor)Quoted Prices in Active Markets for Identical Assets
(Level 1)		Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)
Assets:
Debt and equity securities held in rabbi trusts
$43.3 $29.1 $14.2 $— 
Equity securities
28.9 28.9 — — 
Interest rate cap
12.9 — — 12.9 
$85.1 $58.0 $14.2 $12.9 
Liabilities:
Debt derivative liabilities
$15.1 $— $— $15.1 
Deferred compensation liabilities21.0 — 21.0 — 
Contingent consideration liabilities14.7 — — 14.7 
$50.8 $— $21.0 $29.8 
December 30, 2022 (Predecessor)Quoted Prices in Active Markets for Identical Assets
(Level 1)		Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs
(Level 3)
Assets:
Debt and equity securities held in rabbi trusts
$36.6 $24.8 $11.8 $— 
Equity securities25.5 25.5 — — 
$62.1 $50.3 $11.8 $— 
Liabilities:
Deferred compensation liabilities
$26.0 $— $26.0 $— 
Contingent consideration liabilities
7.3 — — 7.3 
$33.3 $— $26.0 $7.3 
Schedule of Reconciliation of Changes in Fair Value of Contingent Consideration The following table summarizes activity for contingent consideration:
Balance as of December 30, 2022 (Predecessor)
$7.3 
Fair value adjustments(7.2)
Fresh-start adjustment
14.9 
Balance as of November 14, 2023 (Predecessor)
$15.0 
Balance as of November 15, 2023 (Successor)
$15.0 
Fair value adjustments(0.3)
Balance as of December 29, 2023 (Successor)
$14.7 
Schedule of Carrying Amount and Fair Value of Long-term Debt
SuccessorPredecessor
December 29, 2023December 30, 2022
Carrying
Value		Fair
Value		Carrying
Value		Fair
Value
Level 1:
14.75% Second-Out Takeback Notes due November 2028
$836.4 $844.4 $— $— 
10.00% first lien senior secured notes due April 2025— — 475.9 425.9 
10.00% second lien senior secured notes due April 2025— — 242.2 216.8 
11.50% first lien senior secured notes due December 2028— — 650.0 552.6 
10.00% second lien senior secured notes due June 2029— — 175.5 176.7 
Level 2:
First-Out Takeback Term Loan Due November 2028
243.4 232.8 — — 
Second-Out Takeback Term Loan Due November 2028
685.5 654.0 — — 
2017 Replacement Term loan due September 2027— — 1,222.1 1,037.8 
2018 Replacement Term loan due September 2027— — 326.9 274.8 
Total Debt$1,765.3 $1,731.2 $3,092.6 $2,684.6 
Schedules of Concentration of Risk
The following table shows net sales attributable to distributors that accounted for 10.0% or more of the Company's total segment net sales:
SuccessorPredecessor
Period from
November 15, 2023
through December 29, 2023		Period from
December 31, 2022
through
November 14, 2023		Period from
June 17, 2022
through
December 30, 2022		Period from
January 1, 2022
through
June 16, 2022		Year Ended December 31, 2021
FFF Enterprises, Inc.23.1 %22.3 %26.1 %11.8 %*%
McKesson Corporation10.8 ****
AmerisourceBergen Corporation*10.0 ***
CuraScript, Inc.
***15.6 26.1 
* Net sales to this distributor were less than 10.0% of total net sales during the respective periods presented above.
The following table shows accounts receivable attributable to distributors that accounted for 10.0% or more of the Company's gross accounts receivable at the end of each period:
SuccessorPredecessor

December 29,
2023

December 30,
2022
AmerisourceBergen Corporation24.2%23.3%
McKesson Corporation20.0 17.3
FFF Enterprises, Inc.*16.2
* Accounts receivable attributable to this distributor was less than 10.0% of total gross accounts receivable at the end of the respective period presented above.
The following table shows net sales attributable to products that accounted for 10.0% or more of the Company's total segment net sales:
SuccessorPredecessor
Period from
November 15, 2023
through December 29, 2023		Period from
December 31, 2022
through
November 14, 2023		Period from
June 17, 2022
through
December 30, 2022		Period from
January 1, 2022
through
June 16, 2022		Year Ended December 31, 2021
Acthar Gel23.5 %22.7 %28.3 %25.4 %26.9 %
INOmax14.5 16.5 16.7 19.0 20.3 
Therakos16.1 13.6 12.5 12.5 12.1 
APAP13.4 11.4 10.7 11.0 *
Schedule of Derivative Liabilities at Fair Value Significant assumptions utilized in the determination of the fair value are as follows:
First and Second-Out Takeback Term Loans:
Input
Scenario 1
Scenario 2
Scenario 3
Remaining term (years)
555
Maturity Date
November 14, 2028November 14, 2028November 14, 2028
Coupon Rate
7.50% - 9.50% + SOFR
7.50% - 9.50% + SOFR
7.50% - 9.50% + SOFR
Probability of mandatory prepayment event before November 2025 (1)
25.00%25.00%6.25%
Estimated timing of mandatory prepayment event before November 2025(1)
August 2024December 2024
August and December 2024
(1) Represents a significant unobservable input

Takeback Notes:
InputScenario 1Scenario 2Scenario 3
Remaining term (years)555
Maturity DateNovember 14, 2028November 14, 2028November 14, 2028
Coupon Rate14.75%14.75%14.75%
Probability of mandatory prepayment event before November 2025 (1)
25.00%25.00%6.25%
Estimated timing of mandatory prepayment event before November 2025 (1)
August 2024December 2024August and December 2024
(1) Represents a significant unobservable input